Gritstone bio Inc
NASDAQ:GRTS

Watchlist Manager
Gritstone bio Inc Logo
Gritstone bio Inc
NASDAQ:GRTS
Watchlist
Price: 0.0193 USD Market Closed
Market Cap: 2.3m USD

Operating Margin
Gritstone bio Inc

-933.6%
Current
-701%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-933.6%
=
Operating Profit
-136.5m
/
Revenue
14.6m

Operating Margin Across Competitors

No Stocks Found

Gritstone bio Inc
Glance View

Market Cap
2.3m USD
Industry
Biotechnology

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company is headquartered in Emeryville, California and currently employs 193 full-time employees. The company went IPO on 2018-09-28. The firm discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The firm has an infectious disease pipeline, which includes two programs in clinical-stage development: CORAL, a second-generation COVID-19 vaccine program that may have pan-coronavirus potential to protect against future coronavirus pandemics, and an HIV therapeutic/cure vaccine candidate that are collaborating on with Gilead Sciences, Inc. The Company’s product candidates include GRT-C907 (ChAd)/R908 (samRNA), GRT- C909 (ChAd)/R910 (samRNA), GRT-C909 (ChAd)/R910 (samRNA), GRT-R914 (samRNA), GRT-R912 (samRNA) and GRT-R918 (samRNA).

GRTS Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-933.6%
=
Operating Profit
-136.5m
/
Revenue
14.6m
What is the Operating Margin of Gritstone bio Inc?

Based on Gritstone bio Inc's most recent financial statements, the company has Operating Margin of -933.6%.

Back to Top